CINECA IRIS Institutional Research Information System

BOCCHIO CHIAVETTO, LUISELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.670
EU - Europa 6.875
AS - Asia 1.805
AF - Africa 264
SA - Sud America 147
Continente sconosciuto - Info sul continente non disponibili 22
OC - Oceania 5
Totale 17.788
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.529
RU - Federazione Russa 3.387
DE - Germania 1.495
CN - Cina 779
SG - Singapore 642
UA - Ucraina 608
GB - Regno Unito 345
SE - Svezia 285
IT - Italia 249
CM - Camerun 236
FR - Francia 155
FI - Finlandia 134
CA - Canada 122
BR - Brasile 105
IE - Irlanda 95
KR - Corea 94
TR - Turchia 88
PL - Polonia 84
VN - Vietnam 84
IN - India 31
EU - Europa 22
HK - Hong Kong 16
EC - Ecuador 14
MX - Messico 12
ES - Italia 10
IL - Israele 10
AR - Argentina 8
ZA - Sudafrica 8
BD - Bangladesh 7
ID - Indonesia 7
PE - Perù 7
SA - Arabia Saudita 7
MA - Marocco 6
CO - Colombia 5
IR - Iran 5
HU - Ungheria 4
JP - Giappone 4
KE - Kenya 4
PK - Pakistan 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
AU - Australia 3
BE - Belgio 3
IQ - Iraq 3
LT - Lituania 3
AM - Armenia 2
AZ - Azerbaigian 2
BO - Bolivia 2
DZ - Algeria 2
EE - Estonia 2
GR - Grecia 2
JO - Giordania 2
KZ - Kazakistan 2
MN - Mongolia 2
MY - Malesia 2
NL - Olanda 2
RO - Romania 2
TH - Thailandia 2
TW - Taiwan 2
BB - Barbados 1
BF - Burkina Faso 1
BJ - Benin 1
BY - Bielorussia 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GE - Georgia 1
GF - Guiana Francese 1
GM - Gambi 1
GP - Guadalupe 1
HN - Honduras 1
HT - Haiti 1
IS - Islanda 1
KI - Kiribati 1
KY - Cayman, isole 1
LY - Libia 1
MU - Mauritius 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
SC - Seychelles 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 17.788
Salva come PNG Salva come JPEG
Città #
Fairfield 1.564
Ashburn 784
Woodbridge 699
Seattle 696
Houston 661
Beijing 658
Cambridge 604
Jacksonville 560
Chandler 539
Wilmington 504
Moscow 305
Ann Arbor 213
Dallas 185
Singapore 185
London 145
The Dalles 110
Ottawa 106
Boardman 103
Chicago 95
Naples 93
Seoul 93
Dublin 92
Lawrence 90
Princeton 86
New York 76
Kraków 65
Helsinki 64
Rome 63
San Diego 49
Saint Petersburg 35
Los Angeles 34
Ho Chi Minh City 33
Frankfurt am Main 31
Portsmouth 28
Yubileyny 25
Lauterbourg 19
Hanoi 17
Nanjing 17
Milan 16
Norwalk 16
Prescot 16
Hong Kong 15
San Francisco 14
Cedar Knolls 13
Kunming 13
Redwood City 13
Chiswick 12
Guangzhou 12
Warsaw 11
Düsseldorf 10
Mumbai 10
Hefei 9
Islington 9
Kilburn 9
Mexico City 9
Roubaix 9
São Paulo 9
Atlanta 8
Dearborn 8
Hounslow 8
Falls Church 7
Johannesburg 7
Mcallen 7
Wroclaw 7
Council Bluffs 6
St Petersburg 6
Boston 5
Brooklyn 5
Chengdu 5
Guayaquil 5
Nanchang 5
Quito 5
Redmond 5
St Louis 5
Stockholm 5
Bexley 4
Biên Hòa 4
Da Nang 4
Guarulhos 4
Nairobi 4
New Bedfont 4
Rio de Janeiro 4
Santa Clara 4
Shanghai 4
Toronto 4
West Jordan 4
Ankara 3
Brussels 3
Caxias do Sul 3
Chennai 3
Istanbul 3
Jinan 3
Kansas City 3
Kocaeli 3
Manchester 3
Munich 3
Porto Alegre 3
Redondo Beach 3
Rimini 3
Riyadh 3
Totale 10.146
Salva come PNG Salva come JPEG
Nome #
The -1727 A/T, -50 C/T and (CAA)(n) repeat GSK-3 beta gene polymorphisms and resistance to antipsychotics in schizophrenia 584
Immune and metabolic alterations in first episode psychosis (FEP) patients 377
Association between baseline serum vascular endothelial growth factor levels and response to electroconvulsive therapy. 330
Peripheral whole blood microRNA alterations in major depression and bipolar disorder 297
BDNF serum levels, but not BDNF Val66Met genotype, are correlated with personality traits in healthy subjects 287
Absolute Measurements of Macrophage Migration Inhibitory Factor and Interleukin-1-β mRNA Levels Accurately Predict Treatment Response in Depressed Patients 286
Inflammation and neuronal plasticity: a link between childhood trauma and depression pathogenesis 284
Allelic variation in the human prodynorphin gene promoter and schizophrenia 269
Effect of repetitive transcranial magnetic stimulation on serum brain derived neurotrophic factor in drug resistant depressed patients 259
Association between the BDNF 196 A/G polymorphism and sporadic Alzheimer's disease 254
Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects. 254
Serum leptin levels are higher in females affected by frontotemporal lobar degeneration than Alzheimer's disease 250
Promoter haplotypes of interleukin-10 gene and sporadic Alzheimer's disease 250
Aspetti biologici e neuropsicologici del maltrattamento e abuso infantili 249
Effetti biomolecolari del maltrattamento infantile: il ruolo dell'epigenetica e dell'infiammazione 249
-G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study 244
BDNF Val66Met polymorphism and protein levels in Amniotic Fluid 241
Serum levels of brain-derived neurotrophic factor in drug-naive obsessive-compulsive patients: A case-control study 239
Abnormal levels of cAMP-dependent protein kinase regulatory subunits in platelets from schizophrenic patients 235
5-HTTLPR and BDNF Val66Met polymorphisms and response to rTMS treatment in drug resistant depression 233
Serum and plasma BDNF levels in major depression: A replication study and meta-analyses 231
Nanomedicine in Psychiatry: New Therapeutic Opportunities from Research on Small RNAs 231
Glucose metabolism alterations in patients with bipolar disorder 230
Alterations of Brain-Derived Neurotrophic Factor Serum Levels in Patients with Alcohol Dependence 230
Distinct cerebrospinal fluid amyloid-beta peptide signatures in cognitive decline associated with Alzheimer's disease and schizophrenia 229
Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study 228
Haptoglobin polymorphism and schizophrenia: Genetic variation on chromosome 16 226
Association between promoter polymorphic haplotypes of interleukin-10 gene and schizophrenia 224
Serum Levels of Insulin-Like Growth Factor-1 and Obsessive-Compulsive Disorder: A Case-Control Study 223
Cerebrospinal fluid markers for Alzheimer's disease in a cognitively healthy cohort of young and old adults. 223
Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients 223
Micro spies from the brain to the periphery: new clues from studies on microRNAs in neuropsychiatric disorders. 222
Insulin-like growth factor binding protein 2 in bipolar disorder: An expression study in peripheral tissues 222
BDNF Genotype and Baseline Serum Levels in Relation to Electroconvulsive Therapy Effectiveness in Treatment-Resistant Depressed Patients 217
miR-146a and miR-181a are involved in the progression of mild cognitive impairment to Alzheimer's disease 215
Increased serum interleukin-8 and interleukin-10 in schizophrenic patients resistant to treatment with neuroleptics and the stimulatory effects of clozapine on serum leukemia inhibitory factor receptor 213
Blood microRNA changes in depressed patients during antidepressant treatment 213
Altered gene expression in schizophrenia: findings from transcriptional signatures in fibroblasts and blood 213
A multi-element psychosocial intervention for early psychosis (GET UP PIANO TRIAL) conducted in a catchment area of 10 million inhabitants: study protocol for a pragmatic cluster randomized controlled trial 213
Blood microRNA longitudinal changes in depressed patients during antidepressant treatment 212
Effects of Intranasal Oxytocin on Long-Term Memory in Healthy Humans: A Systematic Review 209
Reduced peripheral brain-derived neurotrophic factor mRNA levels are normalized by antidepressant treatment 209
Vascular Endothelial Growth Factor (VEGF) serum concentration during electroconvulsive therapy (ECT) in treatment resistant depressed patients 207
Season of birth and inflammatory response system in schizophrenia 206
Markers of Alzheimer's disease in a population attending a memory clinic 205
Influence of serotonin receptor 2A His452Tyr polymorphism on brain temporal structures: a volumetric MR study 204
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers 203
Study of the in vitro modulation exerted by the antidepressant drug escitalopram on the expression of candidate microRNAs and their target genes 202
G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study 200
Neurobiological and clinical effect of metacognitive interpersonal therapy vs structured clinical model: study protocol for a randomized controlled trial 200
Effect of the XbaI polymorphism of estrogen receptor alpha on postmenopausal gray matter 198
Lack of association between MnSOD gene polymorphism and sporadic Alzheimer's disease 198
VEGF serum levels in depressed patients during SSRI antidepressant treatment 197
Serum brain-derived neurotrophic factor (BDNF) levels in attention deficit-hyperactivity disorder (ADHD) 195
Serum Brain-Derived Neurotrophic Factor Levels in Different Neurological Diseases 191
Effects of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with typical neuroleptics 191
Influence of clotting duration on brain-derived neurotrophic factor (BDNF) dosage in serum. 191
Supporting evidence for using biomarkers in the diagnosis of MCI due to AD 185
Serum brain-derived neurotrophic factor (BDNF) levels in attention deficit-hyperactivity disorder (ADHD) 184
Analysis of miRNome expression profiles in hippocampus of rats treated with antidepressants 175
No occurrence of the glutamate transporter EAAT2 A206G polymorphism in schizophrenic subjects 175
Correlations between immune and metabolic serum markers and schizophrenia/bipolar disorder polygenic risk score in first-episode psychosis 163
Association between IL-1 beta-511C/T and IL-1RA (86bp)n repeats polymorphisms and schizophrenia 156
Association study of-1727 A/T,-50 C/T and (CAA)(n) repeat GSK-3 beta gene polymorphisms with schizophrenia 155
Association study and meta-analysis of-308 A/G functional polymorphism in TNF alpha gene with schizophrenia 153
Association between IL-1 cluster and IL-10 gene polymorphisms and schizophrenia 153
Gene-environment interaction in major depression: focus on experience-dependent biological systems 153
Association study between -1727A/T, -50C/T and (CAA)(N) repeat GSK-3beta gene polymorphisms and Bipolar Disorder 149
CYP2D6 polymorphism in patients with Alzheimer's disease in treatment with cholinesterase inhibitors 148
Childhood trauma and glucose metabolism in patients with first-episode psychosis 147
Influence of G1730A polymorphism of estrogen receptor beta gene on brain morphology in postmenopausal women 143
The cytokine network genes and resistance to antipsychotics in schizophrenia 141
Peripheral BDNF levels and personality traits in a sample of subjects non affected by psychiatric diseases 139
Evidence in Support of the AD Biomarker Dynamic Model from a Memory Clinic Naturalistic Series of Patients with Mild Cognitive Impairment 139
Serum brain derived neurotrophic factor concentrations in attention deficit hyperactivity disorder (ADHD) 136
Brain-derived neurotrophic factor as potential diagnostic biochemical marker of depressive state 131
Serum and plasma BDNF levels in major depression: Replication study plus meta-analysis 130
miR-146a Plasma Levels Are Not Altered in Alzheimer's Disease but Correlate With Age and Illness Severity 126
Plasma Aβ42 as Biomarker of Prodromal Alzheimer's Disease Progression in Patients with Amnestic Mild Cognitive Impairment: Evidence from the PharmaCog/E-ADNI Study 124
Myeloid microvesicles in CSF are associated with myelin damage and neuronal loss in mild cognitive impairment and alzheimer disease. 123
Genetic determinants of circulating VEGF levels in major depressive disorder and electroconvulsive therapy response 116
Molecular mechanisms of brain stimulation. (Chapter 11). 113
Alterations observed in the interferon α and β signaling pathway in MDD patients are marginally influenced by cis-acting alleles 111
A machine learning approach on whole blood immunomarkers to identify an inflammation-associated psychosis onset subgroup. 90
Classification of Psychoses Based on Immunological Features: A Machine Learning Study in a Large Cohort of First-Episode and Chronic Patients 87
Schizophrenia risk conferred by rare protein-truncating variants is conserved across diverse human populations 83
Inflammation-related microRNAs are involved in stressful life events exposure and in trauma-focused psychotherapy in treatment-resistant depressed patients 76
Clinical validation of a combinatorial PharmAcogeNomic approach in major Depressive disorder: an Observational prospective RAndomized, participant and rater-blinded, controlled trial (PANDORA trial) 68
P.264 Association of single nucleotide polymorphisms in the 3’ untranslated region of SLC1A2 with major depressive disorder and relative endophenotypes 65
Vascular endothelial growth factor (VEGF) serum: putative predictive biomarkers for the electroconvulsive therapy (ECT) in depressed patients 63
Reduction of oxytocin plasma levels in borderline personality disorder and normalization induced by psychotherapies 51
Plasma microRNA Levels After Electroconvulsive Therapy in Treatment-Resistant Depressed Patients 42
Can We Modulate Our Second Brain and Its Metabolites to Change Our Mood? A Systematic Review on Efficacy, Mechanisms, and Future Directions of "Psychobiotics" 30
null 5
null 2
null 1
null 1
null 1
Totale 17.948
Salva come PNG Salva come JPEG
Categoria #
all - tutte 92.489
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 92.489
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.262 0 0 0 0 0 243 322 142 125 116 247 67
2021/2022598 108 59 128 46 9 21 21 139 33 23 8 3
2022/20231.614 176 11 11 221 167 344 1 230 299 43 87 24
2023/2024558 27 40 62 68 59 86 21 10 0 16 5 164
2024/20254.245 34 22 18 3 113 319 2.282 779 302 62 183 128
2025/20261.122 181 102 371 286 168 14 0 0 0 0 0 0
Totale 17.948